Hormone helps prevent muscle loss in mice on high fat diets, USC study finds
Researchers also identify molecular pathway that can inform development of treatments for muscle-wasting conditions such as sarcopenia.
2021-02-23
(Press-News.org) A new study suggests that a hormone known to prevent weight gain and normalize metabolism can also help maintain healthy muscles in mice. The findings present new possibilities for treating muscle-wasting conditions associated with age, obesity or cancer, according to scientists from the University of Southern California Leonard Davis School of Gerontology.
The research, published this month in the American Journal of Physiology-Endocrinology and Metabolism, addresses the related problems of age and obesity-induced muscle loss, conditions which can lead to increased risk of falls, diabetes and other negative health impacts. It also adds to a growing number of findings describing beneficial effects of MOTS-c, a mitochondrial-derived peptide that is known to mimic the effects of exercise.
In this study, treating mice on a high-fat diet with MOTS-c helped prevent obesity-associated muscle atrophy by decreasing levels of myostatin, a protein that inhibits muscle growth-- myostatin levels were 40% lower in MOTS-c treated mice compared to control mice. The researchers also found that higher MOTS-c levels in humans were correlated with lower levels of myostatin.
The mice findings show MOTS-c improves not only metabolic function but muscle mass as well.
Through molecular analysis, the researchers also identified the specific signaling pathway regulated by MOTS-c, demonstrating for the first time "that MOTS-c modulates the CK2-PTEN-AKT-FOXO1 pathway to inhibit myostatin expression and muscle wasting," and suggesting that the exercise mimetic effect of MOTS-c may be derived from its previously unknown role as a myostatin inhibitor, according to the paper.
"Knowing the signaling pathway affected by MOTS-c is really important to the discovery of possible treatments," says corresponding author Su Jeong Kim, a research associate professor at the USC Leonard Davis School. "This insight provides a target for potential drug development efforts and can be rapidly translated into clinical trials of MOTS-c and related analogues."
Though several other myostatin inhibitors have been identified, they have yet to successfully reduce muscle wasting conditions in clinical trials. This may be because improving muscle mass alone is not enough, say the USC researchers. They believe boosting mitochondrial function is also key and say that MOTS-c-derived treatments could be especially promising in this regard.
Co-corresponding author Pinchas Cohen, professor of gerontology, medicine and biological sciences and dean of the USC Leonard Davis School, along with Changhan David Lee, assistant professor at the USC Leonard Davis School, first described MOTS-c and its effects on metabolism in 2015. Their mice studies have shown that MOTS-c administration improves both high-fat diet- and aging-induced insulin resistance as well as exercise capacity and median life span.
"Taken together, our work suggests that MOTS-c can address mitochondrial dysfunction," says Cohen. "This study can help improve healthy aging by opening up new avenues for research on how to treat conditions such as insulin resistance-induced skeletal muscle atrophy as well as other muscle-wasting conditions, including sarcopenia."
INFORMATION:
This study was conducted in collaboration with Hiroshi Kumagai (lead author) and Noriyuki Fuku from the Graduate School of Health and Sports Science, Juntendo University, Chiba, Japan; Ana Raquel Coelho and Paulo J. Oliveira from the Center for Neuroscience and Cell Biology, University of Coimbra, Portugal; Hirofumi Zempo from Tokyo Medical and Dental University, Japan; Seiji Maeda, Faculty of Health and Sport Sciences, University of Tsukuba, Japan; and Junxiang Wan, Hemal Mehta , Kelvin Yen, and Amy Huang of the USC Leonard Davis School of Gerontology.
This work was supported by a Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging to Kim, by R01AG061834, P01AG034906, R56AG062693 and an AFAR BIG AWARD grants to Cohen, by the Fundação Luso-Americana para o Desenvolvimento (FLAD) Healthcare 2020 grant to Oliveira, and by a PhD fellowship from Portuguese FCT SFRH/BD/103399/2014) to Coelho. Cohen is a co-founder, stockholder and board member of Cohbar Inc. CohBar is developing analogues of mitochondrial peptides including of MOTS-c for metabolic diseases of aging and is in clinical trials with a MOTS-c analogue.
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-23
Scientists at the University of Adelaide have challenged the common assumption that genetic diversity of a species is a key indicator of extinction risk.
Published in the journal PNAS, the scientists demonstrate that there is no simple relationship between genetic diversity and species survival. But, Dr Joao Teixeira and Dr Christian Huber from the University of Adelaide's School of Biological Sciences conclude, the focus shouldn't be on genetic diversity anyway, it should be on habitat protection.
"Nature is being destroyed by humans at a rate never seen before," says computational biologist Dr Huber. "We burn ...
2021-02-23
COLUMBUS, Ohio - Scientists from around the world have published more than 87,000 papers about coronavirus between the start of the COVID-19 pandemic and October 2020, a new analysis shows.
Even given the importance of the pandemic, researchers were surprised by the huge number of studies and other papers that scientists produced on the subject in such a short time.
"It is an astonishing number of publications - it may be unprecedented in the history of science," said Caroline Wagner, co-author of the study and associate professor in the John Glenn College of Public Affairs at The Ohio State University.
"Nearly all of the scientific community around the world turned its attention to this one issue."
Wagner conducted the analysis with Xiaojing Cai from Zhejiang University in ...
2021-02-23
A team of researchers designed and manufactured a new sodium-ion conductor for solid-state sodium-ion batteries that is stable when incorporated into higher-voltage oxide cathodes. This new solid electrolyte could dramatically improve the efficiency and lifespan of this class of batteries. A proof of concept battery built with the new material lasted over 1000 cycles while retaining 89.3% of its capacity--a performance unmatched by other solid-state sodium batteries to date.
Researchers detail their findings in the Feb. 23, 2021 issue of Nature Communications.
Solid state batteries hold the promise of safer, cheaper, and longer lasting batteries. Sodium-ion chemistries are particularly promising because sodium is low-cost and abundant, as opposed ...
2021-02-23
ROCKVILLE, MD - Coronaviruses exploit our cells so they can make copies of themselves inside us. After they enter our cells, they use our cell machinery to make unique tools of their own that help them generate these copies. By understanding the molecular tools that are shared across coronaviruses, there is potential to develop treatments that can not only work in the current COVID-19 pandemic, but in future coronavirus outbreaks as well. Rockefeller University researchers in the labs of Tarun Kapoor and Shixin Liu, including postdoctoral associate ...
2021-02-23
ROCKVILLE, MD - A tenth of all intensive care unit patients worldwide, and many critical patients with COVID-19, have acute respiratory distress syndrome (ARDS). Therapeutic hypothermia, an intentional cooling of the body, has been suggested as a way to improve ARDS. New research by Chiara Autilio and colleagues in the lab of Jesus Perez-Gil at the Complutense University of Madrid shows not only how therapeutic hypothermia works in the lungs at the molecular level, but also why it could be successfully applied to ARDS. Autilio and her colleagues' work was published in Nature Scientific Reports in January 2021 and will be presented ...
2021-02-23
ROCKVILLE, MD - The remarkable genetic scissors called CRISPR/Cas9, the discovery that won the 2020 Nobel Prize in Chemistry, sometimes cut in places that they are not designed to target. Though CRISPR has completely changed the pace of basic research by allowing scientists to quickly edit genetic sequences, it works so fast that it is hard for scientists to see what sometimes goes wrong and figure out how to improve it. Julene Madariaga Marcos, a Humboldt postdoctoral fellow, and colleagues in the lab of Professor Ralf Seidel at Leipzig University in Germany, found a way to analyze the ultra-fast movements of CRISPR enzymes, which will help researchers understand how they recognize their target sequences in hopes of improving the specificity. Madariaga Marcos will present ...
2021-02-23
New compound targets neurons that initiate voluntary movement
After 60 days of treatment, diseased brain cells look like healthy cells
More research needed before clinical trial can be initiated
CHICAGO and EVANSTON--- Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
In addition to ALS, upper motor neuron degeneration also results in other motor neuron diseases, such as hereditary spastic paraplegia (HSP) and primary lateral sclerosis (PLS).
In ALS, movement-initiating nerve cells in the brain (upper motor neurons) and muscle-controlling ...
2021-02-23
According to a 2017 UCLA study, students with ADHD make up about 6% of the college student population and represent the most common type of disability supported by college disability offices. But are these students receiving enough academic support from their institutions? Despite ADHD being prevalent among college students, there has been little research focused on how having ADHD impacts the transition to college and ongoing academic success. Until now.
New research from George DuPaul, professor of school psychology and associate dean for research in Lehigh University's College of Education, and colleagues confirms students with ADHD face consequential challenges in succeeding and completing ...
2021-02-23
DURHAM, N.C. -- Younger, smaller trees that comprise much of North America's eastern forests have increased their seed production under climate change, but older, larger trees that dominate forests in much of the West have been less responsive, a new Duke University-led study finds.
Declines in these trees' seed production, or fecundity, could limit western forests' ability to regenerate following the large-scale diebacks linked to rising temperatures and intensifying droughts that are now occurring in many states and provinces.
This continental divide, reported for the ...
2021-02-23
In recent years, researchers have discovered ways to remove specific fears from the brain, increase one's own confidence, or even change people's preferences, by using a combination of artificial intelligence and brain scanning technology. Their technique could lead to new treatments for patients with conditions such as post-traumatic stress disorder (PTSD), phobias or anxiety disorders.
But while this technique is extremely promising, in some individuals it remains unsuccessful. Why are there such differences in outcome? Better understanding how the brain can self-regulate its own activity patterns would go a long way toward establishing the technique for clinical use. The researchers who spearheaded this technique have thus released a unique dataset ...
LAST 30 PRESS RELEASES:
[Press-News.org] Hormone helps prevent muscle loss in mice on high fat diets, USC study finds
Researchers also identify molecular pathway that can inform development of treatments for muscle-wasting conditions such as sarcopenia.
